Published ahead of print on June 25, 2009, doi:10.1164/rccm.200903-0322OC Am. J. Respir. Crit. Care Med., Volume 180, Number 7, October 2009, 657-665 A more recent version of this article appeared on October 1, 2009
Submitted on March 2, 2009 Contribution of Epithelial Derived Fibroblasts to Bleomycin Induced Lung FibrosisHarikrishna Tanjore1,1 Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States, 2 Department of Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States, 3 Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Department of Cell and Developmental Biology, Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Veteran Affairs Medical Center, Nashville, Tennessee, 4 Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States; Department of Veterans Affairs Medical Center, Nashville, Tennessee, United States * To whom correspondence should be addressed. E-mail: william.lawson{at}vanderbilt.edu.
Rationale: Lung fibroblasts are key mediators of fibrosis resulting in accumulation of excessive interstitial collagen and extracellular matrix, but their origins are not well defined.
Objectives: We aimed to elucidate the contribution of lung epithelium derived fibroblasts via epithelial-mesenchymal transition (EMT) in the intratracheal bleomycin model.
Methods: Primary type II alveolar epithelial cells (AECs) were cultured from Immortomice and exposed to Transforming Growth Factor Key words: EMT epithelial mesenchymal transition fibroblasts S100A4 lung epithelium
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||